Evaluation of BRD4 as potential target in JAK2 V617F+MPN cells

被引：0
|
作者：
Keller, A. [1 ]
Peter, B. [1 ,2 ]
Zuber, J. [3 ]
Valent, P. [1 ,2 ]
Hadzijusufovic, E. [1 ,2 ,4 ]
机构：
[1] Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria
[2] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria
[3] Res Inst Mol Pathol, A-1030 Vienna, Austria
[4] Univ Vet Med, Dept Compan Anim & Horse, Small Anim Clin, Internal Med, Vienna, Austria
来源：
Oncology Research and Treatment | 2015年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P755
引用
收藏
页码：226 / 227
页数：2
相关论文
共 50 条
  • [1] Identification of the Epigenetic Reader BRD4 As a Novel Therapeutic Target in JAK2 V617F+MPN Cells
    Keller, Alexandra
    Peter, Barbara
    Zuber, Johannes
    Staber, Philipp Bernhard
    Bettelheim, Peter
    Valent, Peter
    Hadzijusufovic, Emir
    BLOOD, 2015, 126 (23)
  • [2] TARGETING OF BRD4 AS A NOVEL THERAPEUTIC CONCEPT IN JAK2 V617F+MPN
    Keller, A.
    Peter, B.
    Zuber, J.
    Berger, D.
    Staber, P. B.
    Bettelheim, P.
    Valent, P.
    Hadzijusufovic, E.
    HAEMATOLOGICA, 2016, 101 : 89 - 89
  • [3] JAK2, the JAK2 V617F mutant and cytokine receptors
    Staerk, J.
    Kallin, A.
    Royer, Y.
    Diaconu, C. C.
    Dusa, A.
    Demoulin, J.-B.
    Vainchenker, W.
    Constantinescu, S. N.
    PATHOLOGIE BIOLOGIE, 2007, 55 (02): : 88 - 91
  • [4] ACTIVATED STAT5 AS NOVEL STEM TARGET IN JAK2 V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS (MPN)
    Hadzijusufovic, E.
    Keller, A.
    Schur, F.
    Cerny-Reiterer, S.
    Hoermann, G.
    Mayerhofer, M.
    Boudot, C.
    Gouilleux, F.
    Muellauer, L.
    Moriggl, R.
    Valent, P.
    HAEMATOLOGICA, 2015, 100 : 524 - 525
  • [5] JAK2 haplotype 46/1 and JAK2 V617F allele burden in MPN: New evidence against the "hypermutability" hypothesis?
    Stolyar, M. A.
    Klimova, O. A.
    Gorbenko, A. S.
    Brenner, E. V.
    Titov, S. E.
    Ivanov, M. K.
    Olkhovskiy, I. A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (01) : E8 - E10
  • [6] Milestones of Post Transplant Monitoring of JAK2 p.V617F Positive MPN Patients
    Lange, Thoralf
    Edelmann, Anja
    Siebolts, Uwe
    Nehring, Claudia
    Jaeckel, Nadja
    Cross, Michael
    Jacqueline, Maier
    Niederwieser, Dietger
    Wickenhauser, Claudia
    BLOOD, 2010, 116 (21) : 1421 - 1421
  • [7] 不同MPN JAK2～(V617F)突变的临床检测方法比较
    丁忠奇
    李毅
    郑国华
    中国医学工程, 2013, 21 (05) : 96 - 97
  • [8] Pitpβ Loss Ameliorates Jak2 V617F-Induced Myeloproliferative Neoplasms (MPN) in Mice
    Vantsev, Nikita
    Zhao, Liang
    Abrams, Charles S.
    Tong, Wei
    BLOOD, 2024, 144 : 1753 - 1754
  • [9] Neutrophilia and the JAK2 V617F Mutation
    Langabeer, Stephen E.
    Haslam, Karl
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 437 - 438
  • [10] Splenomegaly and the JAK2 V617F mutation
    Langabeer, Stephen E.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 37 : E45 - E46
12345